In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae
- PMID: 9832271
- DOI: 10.1007/BF01708352
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae
Abstract
Minimal inhibitory concentrations (MICs) of quinupristin/dalfopristin, penicillin, erythromycin, and clindamycin were determined by a standard agar dilution method for 93 Streptococcus pneumoniae strains isolated from patients with invasive disease in Germany. Quinupristin/dalfopristin showed good activity against 32 penicillin-susceptible/erythromycin-susceptible strains (MIC90 0.5 mg/l; range 0.25-0.5 mg/l) and 31 penicillin-intermediate/erythromycin-susceptible strains (MIC90 0.5 mg/l; range 0.25-1 mg/l). Erythromycin-resistant strains (n=30) were slightly less susceptible (MIC90 1 mg/l; range 0.125-2 mg/l). Quinupristin/dalfopristin was bactericidal (99.9% killing) for all six strains investigated after 2 h at a concentration of 4 mg/l.
Similar articles
-
Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.Pathol Biol (Paris). 2000 Jun;48(5):463-6. Pathol Biol (Paris). 2000. PMID: 10949841
-
Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.Clin Microbiol Infect. 2001 Sep;7(9):503-6. doi: 10.1046/j.1198-743x.2001.00298.x. Clin Microbiol Infect. 2001. PMID: 11678935
-
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.Antimicrob Agents Chemother. 1996 Sep;40(9):2071-4. doi: 10.1128/AAC.40.9.2071. Antimicrob Agents Chemother. 1996. PMID: 8878583 Free PMC article.
-
A review of the in-vitro activity of quinupristin/dalfopristin against intracellular pathogens and mycoplasmas.J Antimicrob Chemother. 1997 May;39 Suppl A:59-62. doi: 10.1093/jac/39.suppl_1.59. J Antimicrob Chemother. 1997. PMID: 9511064 Review.
-
In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.J Antimicrob Chemother. 1997 May;39 Suppl A:15-21. doi: 10.1093/jac/39.suppl_1.15. J Antimicrob Chemother. 1997. PMID: 9511057 Review.
Cited by
-
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008. Drugs. 1999. PMID: 10651391 Review.
-
Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.Drugs. 2007;67(16):2355-82. doi: 10.2165/00003495-200767160-00005. Drugs. 2007. PMID: 17983256 Review.
-
Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.J Clin Microbiol. 2001 May;39(5):1928-31. doi: 10.1128/JCM.39.5.1928-1931.2001. J Clin Microbiol. 2001. PMID: 11326015 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical